Baoping Wang

Baoping Wang


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2018 in BMC Endocrine Disorders
Verified
Journal Article
Open access
PDF file
BWBaoping Wang
Baoping Wang
LYLei-Lei Yang
Lei-Lei Yang
HWHao Wang
Hao Wang
QHQing He
Qing He
ZMZhong-Shu Ma
Zhong-Shu Ma
MLMing Liu
Ming Liu
Pheochromocytoma, especially for noncatecholamine-secreting pheochromocytoma, is an extremely rare cause of ectopic corticotrophin-releasing hormone (CRH) syndrome. A 27-year-old Chinese woman was administered dexamethasone for a skin allergy, but her general condition rapidly deteriorated over a month. She was subsequently hospitalized for typical clinical features of Cushing’s syndrome. Endocrinological investigation confirmed severe hypercortisolism along with elevated plasma adrenocorticotropin hormone (ACTH). However, magnetic resonance imaging (MRI) revealed no pituitary adenoma. Abdominal contrast-enhanced computed tomography (CT) revealed a 6.5 cm heterogeneous right adrenal mass with mildly contrast enhancement. The tumor was found during a routine physical check-up at a local hospital 16 months ago; however, the patient did not have any symptoms and did not seek further medical attention at that time. Laparoscopic resection of the right adrenal tumor led to a rapid remission of Cushing’s syndrome. Based on pathological findings and the presence of normal catecholamine metabolites in her serum and urine, the patient was diagnosed with noncatecholamine-secreting pheochromocytoma. Immunohistochemical staining of the adrenal tumor revealed positive staining for CRH and negative staining for ACTH. This is an extremely rare case of ectopic CRH syndrome caused by an adrenal noncatecholamine-secreting pheochromocytoma. Both ectopic ACTH syndrome and ectopic CRH syndrome should be considered in patients presenting with ACTH-dependent Cushing’s syndrome caused by extrapituitary diseases.

11 September 2026 in Medicine
Verified
Journal Article
Open access
STShaofang Tang
Shaofang Tang
HLHongtao Li
Hongtao Li
ZWZixun Wang
Zixun Wang
BWBaoping Wang
Baoping Wang
ZLZhiqing Li
Zhiqing Li
CDChenlin Dai
Chenlin Dai
This study aimed to analyze the dietary inflammatory index (DII) and its impact on cardiovascular disease (CVD) in individuals with diabetes and to explore the role of the systemic immune-inflammation index (SII) and body mass index (BMI) in the relationship between DII and CVD. Data were obtained from the National Health and Nutrition Examination Survey 2009 to 2023. A generalized linear model was used to examine the influence of DII on CVD among individuals with diabetes. The mediation effect model was employed to examine the relationship between DII, SII, BMI, and CVD among individuals with diabetes. Among 5068 participants, 1243 (24.53%) had diabetes mellitus (DM) with CVD. DII was a risk factor for CVD among individuals with diabetes (odds ratio = 1.140, 95% confidence interval [CI]: 1.091–1.192, P < .001). BMI partially mediated the relationship between DII and CVD among adults with DM, with an effect coefficient of 0.005 (95% CI: 0.001–0.010). SII partially mediated the relationship between DII and CVD among adults with DM, with an effect coefficient of 0.008 (95% CI: 0.001–0.016). Among adults with DM, we should pay attention to monitoring the level of DII and reducing BMI, which may help reduce the risk of comorbid CVD. Furthermore, the assessment and identification of CVD risk among diabetic patients with a high DII using the SII is crucial.

15 May 2026 in Medicine
Verified
Journal Article
Open access
STShaofang Tang
Shaofang Tang
YLYin Li
Yin Li
ZWZixun Wang
Zixun Wang
BWBaoping Wang
Baoping Wang
YLYin Li
Yin Li
CDChenlin Dai
Chenlin Dai
This study aimed to compare patients with diabetes mellitus (DM) and diabetic retinopathy (DR), analyze the relationship between inflammatory biomarkers and depressive symptoms, and further explore the role path of weight management. Data were attained from National Health And Nutrition Examination Survey 2011 to 2020. We calculated the neutrophils-lymphocytes ratio (NLR), systemic inflammatory response index (SIRI), aggregate index of systemic inflammation (AISI) and systemic immune inflammation index (SII). A generalized linear model was used to examine the influence of NLR, SIRI, AISI, and SII on depressive symptoms among DM and DR and the influence of body mass index (BMI) and waist circumference (WC) on depressive symptoms among DR. The mediation effect model was employed to examine the relationship between inflammatory biomarkers, BMI, WC and Patient Health Questionnaire-9 scores among DM. Among 2584 participants with diabetes, 2069 (80.07%) were without retinopathy and 515 (19.93%) were diagnosed with DR, NLR, SIRI, AISI, and SII were risk factors for depressive symptoms among DM (odds ratio [OR] = 1.236, 95% confidence interval [CI] = 1.080–1.415, P = .002; OR = 1.369, 95% CI = 1.155–1.623, P < .001; OR = 1.001, 95% CI = 1.000–1.002, P < .001; OR = 1.001, 95% CI = 1.000–1.001, P = .003). WC fully mediated the relationship between NLR and Patient Health Questionnaire-9 among adults with DM, with effect coefficients of 0.028 (95% CI = 0.005–0.059). BMI and WC were risk factors for depressive symptoms among DR (OR = 1.115, 95% CI = 1.043–1.192, P = .001; OR = 1.044, 95% CI = 1.014–1.074, P = .004). Inflammatory biomarkers are the risk factors of depressive symptoms only in adults with DM, but not in DR. Among adults with DM, we should pay attention to monitoring the level of inflammation and reduce WC instead of BMI, while in DR patients, controlling BMI and WC is an effective strategy to prevent and control depressive symptoms.